Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122950795 | 12295079 | 5 | F | 20160416 | 20160715 | 20160422 | 20160721 | EXP | JP-GLAXOSMITHKLINE-JP2016JPN054059 | GLAXOSMITHKLINE | 64.42 | YR | F | Y | 51.00000 | KG | 20160721 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122950795 | 12295079 | 1 | PS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1000 MG, TID | 20487 | 1000 | MG | TABLET | TID | ||||||
| 122950795 | 12295079 | 2 | SS | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | 60 MG, TID | 0 | 60 | MG | TID | |||||||
| 122950795 | 12295079 | 3 | SS | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | 60 MG, PRN | 0 | 60 | MG | ||||||||
| 122950795 | 12295079 | 4 | C | METGLUCO | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 1D | 0 | 500 | MG | QD | ||||||||
| 122950795 | 12295079 | 5 | C | TRAZENTA | LINAGLIPTIN | 1 | 5 MG, 1D | 0 | 5 | MG | QD | ||||||||
| 122950795 | 12295079 | 6 | C | AMARYL | GLIMEPIRIDE | 1 | 1 MG, 1D | 0 | 1 | MG | QD | ||||||||
| 122950795 | 12295079 | 7 | C | BAYASPIRIN | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 122950795 | 12295079 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 122950795 | 12295079 | 9 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | UNK | 0 | |||||||||||
| 122950795 | 12295079 | 10 | C | MEVALOTIN | PRAVASTATIN SODIUM | 1 | UNK | 0 | |||||||||||
| 122950795 | 12295079 | 11 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 122950795 | 12295079 | 12 | C | INSULIN | INSULIN NOS | 1 | UNK | 0 | |||||||||||
| 122950795 | 12295079 | 13 | C | UBRETID | DISTIGMINE BROMIDE | 1 | UNK | 0 | |||||||||||
| 122950795 | 12295079 | 14 | C | CARDENALIN | DOXAZOSIN MESYLATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122950795 | 12295079 | 1 | Herpes zoster |
| 122950795 | 12295079 | 2 | Herpes zoster |
| 122950795 | 12295079 | 4 | Diabetes mellitus |
| 122950795 | 12295079 | 5 | Diabetes mellitus |
| 122950795 | 12295079 | 6 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122950795 | 12295079 | OT |
| 122950795 | 12295079 | LT |
| 122950795 | 12295079 | HO |
| 122950795 | 12295079 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122950795 | 12295079 | Altered state of consciousness | |
| 122950795 | 12295079 | Blood pressure decreased | |
| 122950795 | 12295079 | Depressed level of consciousness | |
| 122950795 | 12295079 | Metabolic acidosis | |
| 122950795 | 12295079 | Mydriasis | |
| 122950795 | 12295079 | Oedema | |
| 122950795 | 12295079 | Renal disorder | |
| 122950795 | 12295079 | Renal failure | |
| 122950795 | 12295079 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122950795 | 12295079 | 1 | 20160414 | 20160417 | 0 | |
| 122950795 | 12295079 | 2 | 20160414 | 20160415 | 0 | |
| 122950795 | 12295079 | 3 | 201604 | 0 | ||
| 122950795 | 12295079 | 12 | 201604 | 0 |